Ticlopidine-lnduced aplastic anemia: Report of three chinese patients and review of the literature

Acta Haematologica

Volumn 98, Issue 4, 1997, Pages 211-213

  Kao, Tze Wah ^a   Hung, Chien Ching ^a   Chen, Yee Chun ^a   Tien, Hwei Fang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Aplastic anemia; Ticlopidine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; COLONY STIMULATING FACTOR; TICLOPIDINE;

AGE; AGED; AGRANULOCYTOSIS; APLASTIC ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; MEDICAL LITERATURE; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; TICLOPIDINE;

EID: 0030808720     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203626     Document Type: Article

References (17)

1. Editorials: Ticlopidine. Lancet 1991:337:459-460.
2. Haynes RB, Sandler RS, Larson EB, Pater JL, Yatsu FM: A critical appraisal of ticlopidine, a new antiplatelet agent. Arch Intern Med 1992; 152:1376-1380.
3. Gent M, Blakely JA, Easton JD, Ellis DJ, Ha-chinski VC, Harbison JW, Panak E, Roberts RS, Sicurclla J, Turpie AGG, and the CATS Group: The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;i: 1215-1220.
4. Elias M, Rcichman N, Flatau E: Bone marrow aplasia associated w ith ticlopidine therapy. Am J Hematol 1993;44:289-290.
5. Martin-Nunez G, Fdez-Soria RR, Sanchez-Gil F, Benitez-Cano E: Aplastic anemia and ticlopidine. Br J Haematol 1993;85:633-640.
6. Barnett HJM, Eliasziw M, Mcldrum HE, Ro-barts JP: Prevention of ischemic stroke. N Engl J Med 1995:333:460.
7. Lesesve JF, Callat MP, Lenormand B, Mon-conduit M, Noblet C, Moore N, Caron F, Humbert G, Stamatoullas A, Tilly H: Hematological toxicity of ticlopidine. Am J Hematol 1994;47: 149-150.
8. Rodriguez JN, Femandez-Jurado A, Dieguez JC, Amian A, Prados D: Ticlopidine and severe aplastic anemia. Am J Hematol 1994;47: 332.
9. Weiner P, Zidan F, Paz R: Severe aplastic anemia due to ticlopidine. Isr J Med Sci 1995;31: 444-445.
10. Mataix R, Ojeda E, Perez MDC, Jimenez S: Ticlopidine and severe aplastic anemia. Br J Haematol 1992;80:125-132.
11. Gamier G, Taillan B, Pesce A, Chichmanian RM, Dujardin P: Ticlopidine and severe aplastic anemia. Br J Haematol 1992;81:459-460.
12. Troussard X, Mayo P, Mosquet B, Reman O, Leporrier M: Ticlopidine and severe aplastic anemia. Br J Haematol 1992;82:779-780.
13. Khelif A, Assouline D, Ffrench M, Chaumen-tin G, Viala JJ: Ticlopidine and aplastic anemia. Br J Haematol 1993;83:678-679.
14. Mallet L, Mallet J: Ticlopidine and fatal aplastic anemia in an elderly woman. Ann Pharma-cother 1994;28:1169-1171.
15. Ono K, Kurohara K, Yoshihara M, Shimamoto Y, Yamaguchi M: Agranulocytosis caused by ticlopidine and its mechanism. Am J Haematol 1991;37:239-242.
16. Ruiz-Irastorza G, Alonso JJ, Iglesias JJ, Aguirre C: Granulocyte colony-stimulating factor for neutropenia secondary to ticlopidine. Acta Haematol 1994;91:106-107.
17. Nand S, Bayer R, Prinz RA, Felten W, Godwin JE: Granulocyte-macrophage colony stimulating factor for the treatment of drug induced agranulocytosis. Am J Hematol 1991;37:267-269.